Search Within

Pediatric Leukemia

Formats
  1. Journal Article (916)
  2. Meeting Abstract (675)
  3. Book Section (53)
  4. Review (28)
  5. Conference Paper (16)
  6. Guidelines (8)
  7. Editorial (7)
  8. Research Letter (4)
  9. Correspondence (3)
  10. Book Whole (2)
  11. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (1713)
  2. Pediatrics, Department of (1070)
  3. Survivorship Research (671)
  4. Surgery (623)
  5. Radiation Oncology, Department of (578)
  6. Department of Pathology and Laboratory Medicine (467)

More Groups

People
  1. Suzanne Wolden (565)
  2. Michael La Quaglia (413)
  3. Oscar Lin (310)
  4. Peter Steinherz (221)
  5. Neerav Shukla (161)
  6. Tanya Trippett (127)

More People

Years
  1. 2025 (22)
  2. 2024 (52)
  3. 2023 (57)
  4. 2022 (65)
  5. 2021 (70)
  6. 2020 (62)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (216)
  2. Journal of Clinical Oncology (166)
  3. Pediatric Blood and Cancer (148)
  4. Blood (110)
  5. Laboratory Investigation (77)
  6. Journal of Pediatric Surgery (71)

More Publications

Publishers
  1. Elsevier Inc. (317)
  2. American Society of Clinical Oncology (176)
  3. Wiley Periodicals, Inc (150)
  4. American Society of Hematology (117)
  5. Nature Publishing Group (112)
  6. W.B. Saunders Co-Elsevier Inc. (74)

More Publishers

Results (1713)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastoma
    Journal Article

    Sait, S. F.; Bernot, M. R.; Klein, E.; Abramson, D. H.; Francis, J. H.; Gilheeney, S.; Karajannis, M. A.; Spitzer, B.; Wolden, S.; Dunkel, I. J.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Pediatric Surgical Oncology
    Book Whole

    Losty, P. D.; La Quaglia, M.; Sarnacki, S.; Fuchs, J.; Taguchi, T.
    CRC Press (2022)

    Fulltext@MSK | Save
  • Immunological aspects of pediatric cancer and immunotherapy
    Book Section

    Park, J. A.; Cheung, N. K. V.
    In Losty, P. D.; La Quaglia, M.; Sarnacki, S.; Fuchs, J.; Taguchi, T. (Eds.) Pediatric Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Neuroblastoma and adrenal neoplasms
    Book Section

    Davidoff, A. M.; Nuchtern, J.; LaQuaglia, M.
    In Losty, P. D.; La Quaglia, M.; Sarnacki, S.; Fuchs, J.; Taguchi, T. (Eds.) Pediatric Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Prospective clinical genomic profiling of Ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biologic and therapeutic relevance
    Journal Article

    Ogura, K.; Elkrief, A.; Bowman, A. S.; Koche, R. P.; de Stanchina, E.; Benayed, R.; Mauguen, A.; Mattar, M. S.; Khodos, I.; Meyers, P. A.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine
    Meeting Abstract

    Dela Cruz, F. S.; McCarter, J. G.; You, D.; Bouvier, N.; Wang, X.; Guillan, K. C.; Siddiquee, A. H.; Souto, K. B.; Li, H.; Gao, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Updated efficacy and safety of tabelecleucel in patients with Epstein-Barr virus-positive (EBV(+)) leiomyosarcomas (LMS)
    Meeting Abstract

    Jimenez-Kurlander, L. S.; Behr, G.; Bunin, N. J.; Doubrovina, E.; Dinavahi, R.; Gamelin, L.; Ghobadi, A.; Mascarenhas, L.; Nikiforow, S.; O'Reilly, R. J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Unmatched whole-genome sequencing as a clinical tool for hematological neoplasms with significant utility in cases with tumor-in-normal contamination
    Meeting Abstract

    GutieĢrrez-Abril, J.; Leongamornlert, D.; Shukla, N. N.; Sulis, M. L.; Zhou, Y.; Levine, M. F.; Barretta, E.; Lee, S.; Arango-Ossa, J. E.; Gundem, G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • The menin inhibitor SNDX-5613 (revumenib) leads to durable responses in patients (Pts) with KMT2A-rearranged or NPM1 mutant AML: Updated results of a phase (Ph) 1 study
    Meeting Abstract

    Issa, G. C.; Aldoss, I.; DiPersio, J. F.; Cuglievan, B.; Stone, R. M.; Arellano, M. L.; Thirman, M. J.; Patel, M. R.; Dickens, D.; Shenoy, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets
    Meeting Abstract

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S.; Antonescu, C.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N.; Rana, S.; Gularte-Merida, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save